Denali Therapeutics
This role drives the operational backbone of Denali's regulatory strategy, ensuring that every drug candidate's path from IND/CTA through BLA/NDA/MAA stays on track, on time, and aligned across functions. Acting as a trusted cross-functional partner to Regulatory Program Managers, Medical Writing, Regulatory Operations, and development SMEs, this individual anticipates risk before it becomes delay and translates complex, shifting priorities into clear, actionable plans. The role shapes how Regulatory Affairs plans and resources its work, contributing directly to Denali's ability to bring novel therapies for neurodegenerative disease to patients faster.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
Senior Manager, Regulatory Strategy
Beeline Medicines
Regulatory Affairs Strategy Manager (Oncology)
Exelixis
Director, Regulatory CMC
Neurocrine Biosciences
Associate Director, Regulatory Strategy
Beeline Medicines
Senior Manager, Regulatory Affairs
Transforming Hypertrophic Cardiomyopathy Care
Sr. Manager, Regulatory Lead
Alfasigma